National Health (Price and Special Patient Contribution) Determination 2022
8Commonwealth payment of special patient contribution
Start here
Get a plain-English read of 8
Turn the raw legal text into a practical explanation grounded in National Health (Price and Special Patient Contribution) Determination 2022.
8 Commonwealth payment of special patient contribution
(1) For the purposes of subsection 85B(4) of the Act, the circumstances in which the Commonwealth is to pay the special patient contribution for a brand of a pharmaceutical item are: (a) the brand of pharmaceutical item is mentioned in Schedule 2 to this instrument; and (b) the brand has been prescribed in a circumstance mentioned for the brand in Schedule 2 to this instrument; and (c) either: (i) writing the prescription has been authorised in accordance with section 19 of the National Health (Listing of Pharmaceutical Benefits) Instrument 2024; or (ii) if the circumstances are not ones in which writing the prescription requires authorisation—the prescription satisfies the requirements of subsection (2). (2) A prescription satisfies the requirements of this subsection if: (a) the prescription or details of the prescription are submitted to the Chief Executive Medicare; and (b) the Chief Executive Medicare authorises the prescription for the purposes of payment of the special patient contribution and allots a number to the prescription; and (c) the allotted number is written on the prescription. (3) For the purposes of this section, the pharmaceutical item is the listed drug mentioned in Schedule 2: (a) in the form mentioned in Schedule 2 for the listed drug; and (b) with the manner of administration mentioned in Schedule 2 for the form of the listed drug.